Indeed, we were able to show that the combinations EGFR-7B6 and GD2-5B9 or GD2-IgG4-5B9 induce significant elevation in cytokine secretion and in vitro/vivo killing of GBM cells in comparison to the groups having single RevTMs. This evidence concerns the gene EGFR and glioblastoma.